Video

What Treatment Options Are Being Studied for Patients with Type 2 Diabetes?

Conference|APhA Annual Meeting and Exposition - American Pharmacists Association Annual Meeting and Exposition

There are several new options coming down the pipeline for patients with type 2 diabetes.

In this clip, Dhiren Patel, PharmD, CDE, BC-ADM FCCP, who is a professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences School of Pharmacy, discusses with Pharmacy Times the treatment pipeline and what's next for treating patients with diabetes.

Dr. Patel discussed managing diabetes with insulin/GLP-1 receptor agonist combinations during a special session held in conjunction with APhA2017.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Related Content
Immunization, Survey, COVID-19, Vaccine, Pharmacists | Image Credit: Talia Mdlungu/peopleimages.com - stock.adobe.com
October 28th 2024

Survey: 8 in 10 Patients Believe Immunization Protects Them From Public Health Threats

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

GLP-1, diabetes, obesity | Image Credit: Patrick Bay Damsted - stock.adobe.com
October 28th 2024

Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
August 22nd 2024

Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating Solutions

Pharmacy, Biosimilar, Humira, Stelara | Image Credit: Jacob Lund -stock.adobe.com
October 28th 2024

The Future of Biosimilars: Learning from Prior Mistakes

Mark Campbell, PharmD
Sickle cell disease -- Image credit: Iftikhar alam | stock.adobe.com
October 28th 2024

FDA Grants Orphan Drug Designation to AND017 for the Treatment of Sickle Cell Disease

Gillian McGovern, Assistant Editor